Little Cigar Oxidants
NCT06310187 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2026-04-08
Summary
Determine the effects of little cigars on human exposure to tobacco smoke oxidants. In a balanced randomized cross-over study design in cigarette smokers, subjects will be assigned to 3 exposure groups. These include a high oxidant little cigar exposure condition, a low oxidant little cigar exposure condition, and their usual cigarette. Biological samples will be collected before and after product usage.
Conditions
- Tobacco Use
- Oxidative Stress
Interventions
- OTHER
-
High Oxidant Little Cigar
Subjects will be given a high oxidant little cigar to use for outcome measure data collection in the lab before and after product usage.
- OTHER
-
Low Oxidant Little Cigar
Subjects will be given a low oxidant little cigar to use for outcome measure data collection in the lab before and after product usage.
- OTHER
-
Usual Cigarette
Subjects will use their own cigarette for outcome measure data collection in the lab before and after product usage.
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH -
Milton S. Hershey Medical Center
lead OTHER
Principal Investigators
-
Joshua Muscat, Ph.D. · Penn State Hershey College of Medicine
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 21 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-03-23
- Primary Completion
- 2029-08-31
- Completion
- 2029-08-31
Countries
- United States
Study Locations
More Related Trials
-
E-cigarette Nicotine Pharmacokinetic Study
NCT03178981 ·Status: COMPLETED ·Phase: NA
-
A Nicotine Pharmacokinetics and Smoking Behaviour Study Examining Cigarette Ingredients
NCT03272295 ·Status: COMPLETED ·Phase: NA
-
Safety Study of Cytisinicline in Adult Combustible and/or E-cigarette Smokers
NCT06435221 ·Status: COMPLETED ·Phase: PHASE3
-
Adverse Airway Effects From Tobacco and E-Cigarettes
NCT03251053 ·Status: UNKNOWN ·Phase: NA
-
Project 4, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in Pregnant Women
NCT04033237 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pharmacokinetics, Subjective Effects, and Abuse Liability of Nicotine Salt-Based Vaping Products With Tobacco or Unflavored E-liquids, SALTVAPE Study
NCT04231539 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study to Evaluate Safety and Efficacy of CigRx™ in Smokers
NCT01262170 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Study Comparing Nicotine Delivery From E-cigarettes and a Conventional Cigarette in Healthy Subjects
NCT02474849 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Laboratory Smoking of Marijuana "Blunts"
NCT03546790 ·Status: COMPLETED ·Phase: PHASE1
-
Nicotine Pharmacokinetics and Subjective Effects of Oral Nicotine Products Relative to Smokeless Tobacco in Adult Users
NCT06691386 ·Status: COMPLETED ·Phase: NA
-
A Dietary Supplement for Early Cigarette Withdrawal
NCT02042521 ·Status: COMPLETED ·Phase: PHASE2
-
Validation of Biomarkers of Exposure and Host Response
NCT00468234 ·Status: COMPLETED ·Phase: NA
-
Acute Effects of Oral Nicotine Pouches
NCT07128329 ·Status: RECRUITING ·Phase: PHASE1
-
Novel Methods to Reduce Children's Secondhand Smoke Exposure II
NCT01896518 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Pharmacokinetics of Oral Nicotine Pouches and Lozenges in Healthy Adults
NCT04755348 ·Status: COMPLETED ·Phase: NA
-
Baby Albert: Electronic Cigarette Pharmacokinetics (PK) and Abuse Liability
NCT03637452 ·Status: COMPLETED
-
Cardiovascular Effects of Very Low Nicotine Content Cigarettes
NCT05707871 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
A Study to Evaluate Changes in Smokers Using An Oral Tobacco-Derived Nicotine Product
NCT04079933 ·Status: COMPLETED ·Phase: NA
-
Effects of Electronic Cigarette Settings and Liquid Concentrations in Cigarette Smokers and Electronic Cigarette Users
NCT03710590 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics of Nicotine Film in Smokers
NCT02239770 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate Changes in Smokers Using Oral Tobacco-derived Nicotine Products.
NCT03692078 ·Status: COMPLETED ·Phase: NA
-
Comparative Pharmacokinetic Study of New Oral Nicotine Replacement Therapy Products.
NCT01227720 ·Status: COMPLETED ·Phase: NA
-
The Effect of Cycloserine on Smoking Behavior in Nicotine Dependent Smokers
NCT00633256 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Abuse Liability of Very Low Nicotine (VLN) Cigarettes
NCT03559751 ·Status: COMPLETED ·Phase: PHASE1
-
Early Effects of a New Oral Nicotine Replacement Product and NiQuitin™ Lozenge
NCT01075659 ·Status: COMPLETED ·Phase: PHASE2